Regend Therapeutics
10 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Treatment of Chronic Obstructive Pulmonary Disease (COPD) by REGEND007 Cell Therapy (NCT07355868) | Regend Therapeutics | 2026-03-19 |
| A Study of REGEND003 on Patients With Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD) (NCT07275788) | Regend Therapeutics | 2026-01-08 |
| Treatment of Pediatric Bronchiolitis Obliterans by Airway Basal Stem Cells (NCT07239895) | Regend Therapeutics | 2025-11-11 |
| A Clinical Study to Evaluate the Efficacy and Safety of REGEND001 Cell Therapy on Idiopathic Pulmonary Fibrosis (IPF) (NCT06081621) | Regend Therapeutics | 2023-12-11 |
| Treatment of Chronic Obstructive Pulmonary Disease (COPD) With Diffusion Capacity Defect by REGEND001 Cell Therapy (NCT05638776) | Regend Therapeutics | 2022-12-06 |
| Autologous Bronchial Basal Cell Transplantation for Treatment of COPD (NCT03188627) | Regend Therapeutics | 2018-06-12 |
Track Regend Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.